Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 10, 129-138, March 1, 1950]
© 1950 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koletsky, S.
Right arrow Articles by Friedell, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koletsky, S.
Right arrow Articles by Friedell, H. L.

Production of Malignant Tumors in Rats with Radioactive Phosphorus*

Simon Koletsky, M.D., Frederick J. Bonte, M.D. and Hymer L. Friedell, M.D.

(From the Department of Pathology and Radiology, Western Reserve University School of Medicine, Clereland, Ohio)

One of the late effects observed in rats injected with large doses of radioactive phosphorus was the development of malignant neoplasms. Of thirteen tumors, ten were osteogenic sarcomas, situated most frequently in the jaw and also occurring in the spine, tibia, femur, or ilium. Four of the neoplasms metastasized to the lungs. There were three squamous-cell carcinomas involving the face and associated with exophthalmos.

The neoplasms occurred in animals which received (a) a single LD50 dose of P32 (average latent period of 290 days) and (b) repeated doses of 1.5 µc. per gram of P32 (average latent period of 165 days). The incidence of tumor development was about 40 per cent.

Atypical proliferation of bone was usually found in these rats, and the lesions may have served as a precursor to malignant change.

* This work was performed under Contract No. W-31-109-eng-78 between the Atomic Energy Commission and Western Reserve University.

Received 10/17/49.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1950 by the American Association for Cancer Research.